ConductScience.org, home

Paper8395751

Use of octreotide acetate for control of symptoms in patients with islet cell tumors.

Maton PN. World J Surg, 1993. Cited by 36 papers, by iCite.

Cite this record

ConductScience Library. Use of octreotide acetate for control of symptoms in patients with islet cell tumors. Papers, record 8395751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8395751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Use of octreotide acetate for control of symptoms in patients with islet cell tumors.
PubMed
Journal
World J Surg
PubMed
Year
1993
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
36
iCite
Relative citation ratio, by iCite
1.36
iCite
Revised in PubMed
2019-08-25
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Maton PNP N

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenoma, Islet CellMajor topic
OctreotideMajor topic
Pancreatic NeoplasmsMajor topic
Humans

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12575602Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.Gastroenterol Clin North Am1989https://conductscience.org/library/papers/2575602PubMed
290860Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue.Lancet1979https://conductscience.org/library/papers/90860PubMed
32872593Cushing's syndrome in patients with the Zollinger-Ellison syndrome.N Engl J Med1986https://conductscience.org/library/papers/2872593PubMed
42861106Effect of long acting somatostatin-analogue, SMS 201 995, on gut hormone secretion in normal subjects.Experientia1985https://conductscience.org/library/papers/2861106PubMed
56311653Functional and morphologic characterization of human insulinomas.Diabetes1983https://conductscience.org/library/papers/6311653PubMed
66120969Effect of somatostatin on gastrin, insulin and glucagon secretion in two patients with Zollinger-Ellison syndrome.J Endocrinol Invest1981https://conductscience.org/library/papers/6120969PubMed
7173625Proceedings: Investigation and treatment of a recurrent vipoma.Gut1975https://conductscience.org/library/papers/173625PubMed
82565913Long term effects of continuous subcutaneous infusion of the somatostatin analog octreotide in the treatment of acromegaly.J Clin Endocrinol Metab1989https://conductscience.org/library/papers/2565913PubMed
94594711Somatostatin: hypothalamic inhibitor of the endocrine pancreas.Science1974https://conductscience.org/library/papers/4594711PubMed
106128648SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.Life Sci1982https://conductscience.org/library/papers/6128648PubMed
11221293Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate.Diabetes1979https://conductscience.org/library/papers/221293PubMed
121968417Effect of the somatostatin analogue SMS 201-995 on faecal fat excretion in acromegaly.Horm Metab Res1990https://conductscience.org/library/papers/1968417PubMed
136114963Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.J Clin Endocrinol Metab1981https://conductscience.org/library/papers/6114963PubMed
142860768A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.Acta Endocrinol (Copenh)1985https://conductscience.org/library/papers/2860768PubMed
152229321Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly.J Clin Endocrinol Metab1990https://conductscience.org/library/papers/2229321PubMed
164139406Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone.Lancet1974https://conductscience.org/library/papers/4139406PubMed
172543178The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.Acta Endocrinol (Copenh)1989https://conductscience.org/library/papers/2543178PubMed
182906126A case of somatostatinoma: responses to food and SMS 201-995 administration.Pancreas1988https://conductscience.org/library/papers/2906126PubMed
192568300Pharmacological effect of somatostatin on bile secretion in man.Digestion1989https://conductscience.org/library/papers/2568300PubMed
202559036The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors.Gastroenterol Clin North Am1989https://conductscience.org/library/papers/2559036PubMed

See all 55 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.

PMIDTitleJournalYearIn PapersSource
35838801Complete remission of recurrent multiple insulin-producing neuroendocrine tumors of the pancreas with somatostatin analogs: a case report and literature review.Discov Oncol2022https://conductscience.org/library/papers/35838801PubMed
34093445Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34093445PubMed
32121432Somatostatin Analogs in Clinical Practice: a Review.Int J Mol Sci2020https://conductscience.org/library/papers/32121432PubMed
25741154Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors.World J Gastroenterol2015https://conductscience.org/library/papers/25741154PubMed
24312683Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs).Gastrointest Cancer Res2013https://conductscience.org/library/papers/24312683PubMed
22089253Abdominal mass, anemia, diabetes mellitus, and necrolytic migratory erythema.Dig Dis Sci2012https://conductscience.org/library/papers/22089253PubMed
20146582Insulinoma: pathophysiology, localization and management.Future Oncol2010https://conductscience.org/library/papers/20146582PubMed
19693706PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success.Pathol Oncol Res2010https://conductscience.org/library/papers/19693706PubMed
8977344Treatment of the carcinoid syndrome with the longacting somatostatin analogue lanreotide: a prospective study in 39 patients.Gut1996https://conductscience.org/library/papers/8977344PubMed
8943970Mechanisms of bombesin on growth of gastrinoma (PT) in vivo.Dig Dis Sci1996https://conductscience.org/library/papers/8943970PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GHRH2691PubTator's text mininghttps://conductscience.org/library/genes/2691NCBI Gene
SST6750PubTator's text mininghttps://conductscience.org/library/genes/6750NCBI Gene
VIP7432PubTator's text mininghttps://conductscience.org/library/genes/7432NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8395751

GET https://conductscience.org/api/papers/v1/8395751/references?page=2